New bioactive metabolites from the elicited marine sponge-derived bacterium Actinokineospora spheciospongiae sp. nov. by Tawfike, A. et al.
Tawfike et al. AMB Expr            (2019) 9:12  
https://doi.org/10.1186/s13568-018-0730-0
ORIGINAL ARTICLE
New bioactive metabolites from the elicited 
marine sponge-derived bacterium 
Actinokineospora spheciospongiae sp. nov.
Ahmed Tawfike1,2, Eman Zekry Attia3, Samar Yehia Desoukey3, Dina Hajjar4, Arwa A. Makki4, Peter J. Schupp5*, 
RuAngelie Edrada‑Ebel1 and Usama Ramadan Abdelmohsen3*
Abstract 
Several approaches have been dedicated to activate the cryptic gene clusters in the genomes of actinomycetes 
for the targeted discovery of new fascinating biomedical lead structures. In the current study, N‑acetylglucosamine 
was used to maximize the chemical diversity of sponge‑derived actinomycete Actinokineospora spheciospongiae 
sp. nov. HR–ESI–MS was employed for dereplication study and orthogonal partial least square‑discriminant analysis 
was applied to evaluate the HR–ESI–MS data of the different fractions. As a result, two new fridamycins H (1) and I 
(2), along with three known compounds actinosporin C (3), D (4), and G (5) were isolated from the solid culture of 
sponge‑associated actinomycete Actinokineospora spheciospongiae sp. nov., elicited with N‑acetylglucosamine. Char‑
acterization of the isolated compounds was pursued using mass spectrometry and NMR spectral data. Fridamycin H 
(1) exhibited significant growth inhibitory activity towards Trypanosoma brucei strain TC221. These results highlight 
the potential of elicitation in sponge‑associated actinomycetes as an effective strategy for the discovery of new anti‑
infective natural products.
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Introduction
Marine sponge-derived actinomycetes have been rec-
ognized as potential producers of fascinating chemical 
scaffolds such as polyketides, alkaloids, peptides, sterols, 
terpenes and fatty acids (Abdelmohsen et  al. 2014a, c; 
Genilloud 2017; Ibrahim et al. 2018; Van der Meij et  al. 
2017) with diverse pharmacological activities such as 
antichlamydial, antioxidant, antibacterial, antitrypano-
somal, cytotoxic, and antibiofilm (Abdelmohsen et  al. 
2017; Balasubramanian et  al. 2017; Cheng et  al. 2015, 
2017). The strain Actinokineospora spheciospongiae was 
first isolated by Abdelmohsen et al. in 2010 from the Red 
Sea sponge Spheciospongia vagabunda that was collected 
from Ras Mohamed, Egypt (Abdelmohsen et  al. 2010). 
The strain was then described by Kampfer et al. in 2015 
and the draft genome sequence was analysed (Harjes 
et al. 2014; Kampfer et al. 2015). The chemical and biolog-
ical investigation of this strain emphasized the diversity 
of its natural components and resulted in identification of 
several new natural products (Abdelmohsen et al. 2014b; 
Dashti et  al. 2017). Actinomycetes have been found to 
have the major fraction of their secondary metabolites 
to be transcriptionally inactive or “silent” under normal 
laboratory conditions (Abdelmohsen et al. 2015; Dinesh 
et al. 2017; Horn et al. 2015; Letzel et al. 2017; Seyedsay-
amdost 2014). In a study by Letzel et al. (2017), analysis of 
genome sequences of 119 marine actinomycetes reveals 
extraordinary biosynthetic diversity. Several experimen-
tal approaches have been applied to activate and iden-
tify the products of those cryptic genes using biological, 
chemical and genetic elicitations (Abdelmohsen et  al. 
2015; Dashti et  al. 2017; Pettit 2011). In our previous 
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work, Actinokineospora spheciospongiae broth culture 
was elicited with N-acetyl glucosamine (GlcNAc) and 
the metabolic profile was investigated using 1H NMR fin-
gerprint methodology which resulted in identification of 
four new actinosporins (E–H) (Dashti et al. 2017). In the 
present study, the solid culture of Actinokineospora sphe-
ciospongiae sp. nov. was elicited with GlcNAc that led to 
the identification of two new fridamycins (1 and 2), along 
with three known compounds actinosporin C (3), D (4), 
and G (5). Moreover, the antitrypanosomal activity of all 
isolated pure compounds was also investigated.
Materials and methods
Microbial fermentation, extract preparation 
and compounds isolation
Actinokineospora spheciospongiae sp. nov. (DSM 45935T, 
GeneBank accession no. GU318361) was isolated from 
the Red Sea sponge Spheciospongia vagabunda that was 
collected by SCUBA diving from offshore Ras Mohamed, 
Egypt (GPS: 27°47.655 N; 34°12.904 W) in August 2006. 
Two hundred ISP2 agar plates (square 120 × 120  mm), 
each inoculated with 100 µL of a 5  day old liquid cul-
ture of Actinokineospora spheciospongiae and incubated 
at 30  °C for 6 h. The agar plates were then elicited with 
GlcNAc (50 µL/plate of a 50 μM solution, Sigma-Aldrich, 
Darmstadt, Germany). The plates were then incubated 
at 30 °C for 7 days. The agar medium with bacterial bio-
mass was cut into small pieces and transferred to 1  L 
Erlenmeyer flasks. One liter of EtOAc/flask was added to 
submerge the agar pieces and macerate the medium cul-
ture under shaking at 150 rpm for overnight. The macer-
ated medium was subsequently filtered using filter paper 
(A. Hartenstein, Wurzburg, Germany). The filtrates 
were combined and evaporated in a rotary evaporator 
under vacuum (Büchi, Essen, Germany) to yield 850 mg 
of dried crude EtOAc extract, which was fractionated 
on a Sephadex LH20 (50  g, 32–64  µm, 100 × 10  mm, 
Merck, Darmstadt, Germany) column eluting with  H2O/
MeOH (90:10%) to 100% methanol, to yield 12 fractions 
(50 mL each). The highly active fractions (3 and 5) were 
further purified by semi-preparative HPLC (Agilent, 
Waldbronn, Germany) using  H2O/acetonitrile (95:5%) 
initially for 5 min, followed by a linear gradient to 100% 
acetonitrile within 40  min and maintained isocratically 
for further 5 min. Separation was achieved on a prepara-
tive C18 column (5  µm, 10 × 250  mm, Waters XBridge, 
Eschborn, Germany), with a flow rate of 3.0  mL/min 
yielding compounds 1 (1.6 mg) and 2 (1.8 mg) from frac-
tion 3 and compounds 3–5 (2.3, 2.5 and 3  mg, respec-
tively) from fraction 5.
LC–MS analysis
One milligram of dried microbial extracts and/or frac-
tions was dissolved in HPLC-grade MeOH to a final con-
centration of 1 mg/mL and subjected to high resolution 
LC–ESI–MS using Thermo Scientific Exact mass analys-
ers (Thermo Scientific, Karlsruhe, Germany) coupled to 
a Dionex UltiMate 3000 HPLC system. The samples were 
eluted through a C-18 column (ACE, Mainz, Germany) 
with a length of 75  mm, internal diameter of 3.0  mm 
and particle size 5  μm. The mobile phase consisted of 
0.1% formic acid in HPLC-grade water (solvent A) and 
acetonitrile (solvent B). The flow rate was set at 300 µL/
min. Gradient elution was initiated with 10% B for 5 min, 
which was increased to 100% B over 30 min, which was 
maintained for another 5 min before decreasing to 10% B 
in the next min. The column was then equilibrated with 
10% B for 4  min until the end of the run. MS/MS was 
measured using LTQ Orbitrap Thermo scientific mass 
analysers (Thermo Scientific, Karlsruhe, Germany).
Biological activity of the isolated compounds
Antitrypanosomal activity
Antitrypanosomal action had been investigated following 
the method reported by Abdelmohsen et  al. (2014b). In 
brief, Complete Baltz Medium was used for cultivation 
of 104 trypanosomes per mL of the Trypanosoma bru-
cei strain TC 221 (Missionsärztliche Klinik, University of 
Wurzburg). 96-well plate chambers were used for testing 
Trypanosomes versus various concentrations of exam-
ined compounds at 0.25–40 μM in DMSO (1%) to a final 
volume of 200 μL. For controls, DMSO (1%) plus para-
sites without any examined compound were used concur-
rently in each plate. After that, the plates were incubated 
in an atmosphere of  CO2 5% at 37 °C for 24 h. Then, 20 
μL of Alamar Blue was added in each plate and the activ-
ity was measured by light absorption at ʎ 550 nm with a 
reference wavelength of 650 nm using an MR 700 Micro-
plate Reader (Dynatech Engineering Ltd., Willenhall, UK) 
after 48 and 72 h. The quantification of the  IC50 values of 
the examined compounds were processed by linear inter-
polation in triplicate.
Cytotoxicity activity
Macrophages (J774.1) (Missionsärztliche Klinik, Uni-
versity of Wurzburg) were cultivated in Complete Baltz 
Medium free from phenol red. Different concentrations 
of tested compounds (0.25–200  μM) at a cell density of 
1 × 105 cells/mL at 37 °C, 5%  CO2, and 95% humidity for 
24 h, were used for investigation of their cytotoxic prop-
erties against Macrophages (J774.1). After adding of 
Alamar Blue (20 μL), the plates were incubated and the 
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then, determination of the optical densities at ʎ 540 nm 
and a reference wavelength of 630 nm were done after 48 
and 72 h, in the same way as described for the anti-tryp-
ansomal activity (Abdelmohsen et al. 2014b).
Compounds characterization
Fridamycin H (1): Orange powder; [α]D25 + 12° (c 1.5, 
MeOH); UV (MeOH) λ max (log ε) 231 (4.45), 253 (4.51), 
293 (4.37) nm; IR (KBr)νmax 3420, 2962, 1710, 1436, 1340, 
1275, 1065  cm−1; 1H NMR (DMSO-d6, 600  MHz) and 
13C NMR (DMSO-d6, 150  MHz) data, see Table  2; HR-
ESIMS (+) m/z 503.1524 [M+H]+ (calcd. for  C25H26O11, 
503.1553).
Fridamycin I (2): Yellow powder; [α]D25 + 25° (c 1.5, 
MeOH); UV (MeOH) λ max (log ε) 232 (4.54), 253 (4.53), 
294 (4.17) nm; IR (KBr)νmax 3419, 3030, 1700, 1650, 1432, 
1345, 1275, 1065 cm−1; 1H NMR (DMSO-d6, 600 MHz) 
and 13C NMR (DMSO-d6, 150  MHz) data, see Table  3; 
HR-ESIMS (+) m/z 614.2036 [M+Na]+ (calcd. for 
 C32H33NO10Na, 614.2021).
Results
Bioactivity‑guided assay and metabolomic analysis
All fractions were subjected to HPLC-HR-ESIMS anal-
ysis on both negative and positive ionization switch 
modes to cover the maximum number of metabolites. 
The MS dataset was processed and data were extracted 
using MZmine 2.20 based on the established param-
eters (Tawfike et  al. 2017). The dereplication study of 
the active fractions against DNP database revealed the 
presence of known metabolites, but mostly unknown 
hits dominated as shown in Table 1. Metabolites at m/z 
(retention time in minutes) 387.0865 (6.65) [M−H]− and 
401.1025 (10.44) [M−H]−, were dereplicated as G-2N 
 (C23H16O6), an antibiotic formerly reported from actino-
mycete Frankia sp.(Nancy and Mary 1984), and sapto-
mycin F  (C24H18O6), an antibiotic previously isolated 
from Streptomyces sp.(Abe et al. 1993), respectively. The 
aforementioned dereplicated metabolites, depicted in 
Fig.  1, possessed the naphthacene-dione moiety. Addi-
tionally, the mass ion peak at m/z 227.175 [M+H]+ for 
the predicted molecular formula  C12H22N2O2 was derep-
licated as isoleucyl isoleucine anhydride. The latter is a 
dipeptide previously reported from Ustilago cynodontis 
and Beauveria bassiana (Geraci et al. 2000).
The dereplication results highlighted the previously 
reported active compounds that would guide the struc-
ture elucidation of the isolated unknown metabolites. 
Multivariate data analysis (MVDA) was performed for 
the MS dataset of active versus inactive fractions to 
pinpoint the putatively active metabolites in the antit-
rypanosomally-active fractions prior to any further puri-
fication attempts.
To achieve the best discrimination between the active 
and inactive fractions, a supervised orthogonal partial 
least square discriminant analysis (OPLS-DA) was car-
ried out. The OPLS-DA scores plot (Fig.  2a) showed a 
significant discrimination between active and inactive 
fractions revealing a regression fit of 99%  (R2 = 0.99) and 
high predictive ability of  Q2 = 0.96. The current OPLS-
DA model produced the highest predictive power  (Q2) 
Table 1 The dereplication results of the active fractions against DNP database
Polarity m/z Rt Formula Name Source
[M−H]− 387.0865 6.65 C23H16O6 G‑2N Frankia sp. ANP 190107
[M+H]+ 188.1279 7.69 C9H17NO3 Unknown –
[M−H]− 343.0952 8.67 C18H12N6O2 Unknown –
[M+H]+ 227.1753 9.00 C12H22N2O2 Isoleucyl isoleucine anhydride Ustilago cynodontis, Beauveria bassiana
[M−H]− 369.0751 9.84 C19H10N6O3 Unknown –
[M−H]− 1003.325 9.86 – Complex of 501.1586 and 501.1586 m/z
[M−H]− 501.1586 9.86 C31H18N8 Unknown –
[M+H]+ 357.097 9.88 C19H16O7 Fridamycin E Streptomyces parvulus Tu 1989
[M−H]− 401.1025 10.44 C24H18O6 Saptomycin‑F Streptomyces strain HP530
[M+H]+ 357.0968 15.66 C16H8N10O Unknown –
[M−H]− 355.0954 15.67 C19H12N6O2 Unknown –
Fig. 1 Dereplicated structures from the active fractions: G‑2N and 
saptomycin F
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when assessed by cross validation. Moreover, the statis-
tical significance of estimated predictive power of the 
respective model was tested by permutation test which 
exhibited  Q2Y intercept at − 0.81 that indicated a valid 
model. A particularly useful tool that compares the vari-
able magnitude against its reliability is the S-loadings 
plot obtained from the OPLS-DA model and represented 
in Fig.  2b, where axes plotted from the predictive com-
ponent are the covariance p[1] against the correlation p 
(cor) [1]. The S-loadings plot highlighted the metabolites 
distinct for the active fractions that highly correlated to 
their bioactivity.
Fig. 2 a OPLS‑DA score plot of active (red circle) versus inactive fractions (yellow circle). b S‑loading plot showing the putatively active metabolites
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The metabolite at m/z 501.159 (Rt = 9.86  min) 
[M−H]−, equivalent to  C25H26O11 did not match any 
compounds reported in the DNP database while the m/z 
ion at 357.097 (Rt = 9.88 min) [M+H]+ for the predicted 
molecular formula  C19H16O7 was dereplicated for frida-
mycin E, the simplest member of the angucycline family 
of antibiotics that was previously isolated from a mutant 
of Streptomyces parvulus (strain Tu 1989) (Krohn and 
Baltus 1988; Kunzel et  al. 1999). The metabolomics and 
dereplication results (Table 1, Fig. 1) revealed previously 
undescribed putatively active metabolites that motivated 
us to further purify the fractions and identify the active 
compounds via 1D, 2D-NMR and HR–ESIMS.
Structure elucidation of the new isolated compounds
Separation of fraction 3 delivered two hydroxyquinones 
with similar UV spectra (231, 253, 293  nm) indicating 
similar chromophores. A molecular formula of  C25H26O11 
was established for 1 (Fig.  3) by positive HR-ESIMS 
analysis (found at m/z 503.1524 for [M+H]+, calcd. 
503.1553) requiring thirteen degrees of unsaturation 
(Additional file  1: Figure S1). The 600  MHz instrument 
for 1H, 13C, COSY, HSQC and HMBC (optimized for 
J = 8.3 Hz and J = 4.0 Hz) in DMSO-d6 was used for pro-
cessing the NMR spectral analyses. Initial investigation of 
NMR spectral data of 1 (Table 2) exhibited characteris-
tic signals for a C-4 substituted (R)-fridamycin E moiety 
(Krohn and Baltus 1988; Myronovskyi et al. 2016; Vicente 
et al. 2015).
The aromatic region in 1H NMR spectrum (Additional 
file 1: Figure S2) displayed the presence of two different 
aromatic spin systems of ortho-coupled protons; one 
corresponds to a tri-substituted benzene ring consist-
ing of two one-proton doublets at δH 7.95 (J = 7.8  Hz) 
and 7.70 (J = 8.4 Hz) assignable to H-1 and H-3, respec-
tively, in addition to a one proton doublet of doublet at 
δH 7.86 (J = 7.8 and 8.4  Hz), of H-2. Another spin sys-
tem consists of two one-proton doublets at δH 7.78 
(J = 7.8  Hz) and 7.61 (J = 7.8  Hz) assignable to protons 
H-6 and H-7, respectively, of the tetra-substituted aro-
matic system. Moreover, the 1H NMR spectrum showed 
two one-proton doublets at δH 2.88 (J = 13.2 Hz) and 3.03 
(J = 13.2  Hz), attributed to the two geminally coupled 
protons, characteristic for H-11a and H-11b, respectively. 
Fig. 3 Structures of the isolated compounds: fridamycin H (1) and I (2), actinosprin C (3), D (4) and G (5)
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Whereas, the two-protons singlet at δH 2.40 was assign-
able for H-13, belonging to the protons of a methylene 
group directly linked to the carboxyl group. One singlet 
at δH 1.19 together with its corresponding carbon signal 
at δC 26.8 was for the methyl group  (CH3-15) which was 
considerably downfield shifted due to its direct attach-
ment to oxygenated carbon at δC 71.5 (C-12) (Vicente 
et al. 2015). Moreover, the presence of an anomeric pro-
ton signal at δH 5.64 (J = 1.8  Hz; δC 99.3), one methyl 
doublet at δH 1.09 (J = 6 Hz), as well as four one-proton 
multiplets at δH (3.33–3.99) indicated the presence of the 
rhamnose moiety in the structure (Grkovic et  al. 2014). 
The coupling constant of the anomeric proton allowed 
the identification of an α anomer and the absolute con-
figuration of sugar was determined to be L based on the 
literature (Dashti et al. 2017).
The 13C NMR and HSQC spectra (Additional file  1: 
Figures  S3, S5) displayed fourteen resonances compris-
ing five methine  sp2, five methine  sp3, two methylene 
 sp3, two methyl carbons consistent with an angucycline 
core and one glycosidic residue. Three carbonyl carbons 
were displayed, the upfield shifted carbon at δC 172.8 
was attributed to free carboxyl group (C-14), while the 
others resonated at δC 181.2 and 188.9 were assigned to 
quinone carbonyl carbons C-5 and C-10, respectively. 
Additionally two methylene carbons C-11 and C-13 were 
observed; the latter was deshielded to 46.7 ppm in agree-
ment with direct attachment to carboxylic group, while 
the former one was detected at 40.1 ppm due to its direct 
attachment to the aromatic ring that could be confirmed 
by HMBC correlations from H-11a and H-11b (δH 2.88 
and 3.03) to C-7 (δC 141.0) and C-9 (δC 160.3). Two oxy-
genated aromatic carbons were observed at δC 156.8 and 
160.3, assignable to C-4 and C-9, respectively. The for-
mer (C-4) displayed HMBC correlation to the anomeric 
proton of l-rhamnose (δH 5.64, H-1′), confirming the 
attachment of l-rhamnose to C-4 of the anthraquinone 
motif (Fig. 4). Due to a small amount of 1 obtained in this 
study, it was not possible to determine the absolute con-
figuration of C-12. However, as 1 is a 4-O-glycosylated 
fridamycin E, we speculated that the absolute configu-
ration of C-12 of 1 should be the same as that of natu-
rally occurring fridamycin E (Krohn and Baltus 1988) i.e. 
12R. However, it is necessary to obtain more amount of 
1 to determine conclusively the absolute configuration of 
C-12. As a common biosynthesis feature of Streptomyces 
sp., all the naturally identified fridamycin E analogues 
retain the (R) configuration (α-OH and β-CH3) at C-12. 
Whereas the (S) isomers, (α-CH3 and β-OH) at C-12, 
have been only obtained chemosynthetically as the less 
bioactive isomers of fridamycin E analogues (Bruntner 
et  al. 2005; Chen et  al. 2011; Rohr and Thiericke 1992; 
Vicente et al. 2015).
COSY, HSQC and HMBC experiments (Additional 
file 1: Figures S4–S6) were used to support the aforemen-
tioned assignments and the structure of 1, which was a 
new compound that we named fridamycin H.
HR-ESIMS of 2 (Fig.  3) established the molecular 
formula as  C32H33NO10Na (found at m/z 614.2036, 
calcd. 614.2021) [M+Na]+) requiring seventeen 
degrees of unsaturation Additional file  1: Figure S7). 
First investigation of the NMR spectroscopic data of 
2 (Table 3) (Additional file 1: Figures S8–S12) showed 
many signals similar to chemical shifts of those 
reported for 1 (fridamycin H) except for the substitu-
tion of the carboxyl group of 1 with N-benzyl amide 
moiety that was represented by multiplet signals at 
δH 7.25, 7.30 and 7.24 assignable to (H-2″, 6″), (H-3″, 
5″) and H-4″, respectively, in accordance with mono-
substituted benzene ring. Two-protons singlet at δH 
3.54 along with its corresponding carbon signal at δC 
40.9 were for the methylene group  (CH2-16) directly 
attached to the benzene ring and one singlet at δH 
8.17 corresponding to an amine proton (Myronovskyi 
Table 2 1H and 13C NMR data (DMSO-d6, 600 and 150 MHz) 
of 1 
Position δH, mult (J in Hz) δC, type COSY HMBC
1 7.95, d (7.8) 120.6, CH H‑2 C‑3, 10
2 7.86, dd (7.8, 8.4) 135.4, CH H‑1, 3 C‑4, 10a
3 7.70, d (8.4) 123.6, CH H‑2 C‑1, 4a
4 – 156.8, C – –
4a – 122.3, C – –
5 – 181.2, C – –
5a – 133.4, C – –
6 7.61, d (7.8) 118.2, CH H‑7 C‑8, 9a, 5
7 7.78, d (7.8) 141.0, CH H‑6 C‑5a, 9
8 – 133.4, C – –
9 – 160.3, C – –
9a – 115.1, C – –
10 – 188.9, C – –





40.1,  CH2 – C‑7, 9
12 – 71.5, C – –
13 2.40, s 46.7,  CH2 – C‑11
14 – 172.8, C – –
15 1.19, s 26.8,  CH3 – C‑11, 13
1′ 5.64, d (1.8) 99.3, CH H‑2′ C‑4′, 5′
2′ 3.99, m 70.5, CH H‑1′ C‑1′
3′ 3.99, m 70.5, CH H‑4′ –
4′ 3.33, m 72.0, CH H‑3′ –
5′ 3.52, m 70.4, CH H‑4′, 6′ –
6′ 1.09, d (6) 18.4,  CH3 H‑5′ C‑5′, 4′
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et al. 2016). Moreover, HMBC correlations from H-16 
(δH 3.54) to C-1″ and C-2″, 6″ at δC 135.45 and 129.7, 
respectively and to amide-type carbonyl carbon at (δC 
173.2) were observed confirming direct attachment 
of the methylene group  (CH2-16) to the benzene ring 
from one side and to the amide moiety from the other 
side (Myronovskyi et al. 2016) (Fig. 4).
COSY, HSQC and HMBC experiments (Additional 
file  1: Figures  S10–S12) were used to support the 
aforementioned assignments and the structure of com-
pound 2, which was a new compound that we named 
fridamycin I.
Separation of fraction 5 delivered three actinosporins 
with similar UV spectra (250, 270, and 320 nm). By com-
paring their spectra (Additional file 1: Figures S13–S21) 
with previously published data (Dashti et al. 2017; Grko-
vic et al. 2014), the structures of these compounds were 
confirmed as actinosporin C (3), D (4) and G (5).
Biological activity of the isolated compounds
All the isolated compounds were tested against Tryp-
anosoma brucei strain TC221 (Abdelmohsen et  al. 
2014b; Huber and Koella 1993). Compound 1 showed 
significant antitrypanosomal activity after 48 and 72 h 
with  IC50 values of 7.18 and 3.35  μM, respectively, 
with no cytotoxicity against J774.1 macrophages  (IC50 
of > 200  μM). While the rest displayed no significant 
antitypanosomal or cytotoxic activity at the concentra-
tion tested.
Discussion
Bioinformatic analyses have revealed the presence of 
large fractions of silent gene clusters in the genome 
sequences of actinomycetes. Innovative strategies had 
been used to induce production of weakly expressed 
secondary metabolites which are not expressed under 
standard fermentation conditions and several approaches 
including biological, chemical, and molecular, have been 
applied to activate those silent natural products in the 
laboratory culture of actinomycetes (Abdelmohsen et al. 
2015). Among those approaches, OSMAC approach (one 
strain many compounds), co-cultivation and applying of 
external chemical elicitors (Romano et  al. 2018). In our 
previous studies the genome sequences (Harjes et  al. 
2014) as well as metabolomic analyses (Abdelmohsen 
et al. 2014b) of Actinokineospora spheciospongiae sp. nov. 
showed unexplored chemical potential. Actinosporins A 
and B had been isolated using broth culture of Actinoki-
neospora sp. strain EG49 (Abdelmohsen et  al. 2014b), 
while supplementing the same culture with calcium algi-
nate beads allowed identification of actinosporins C and 
D have been identified (Grkovic et  al. 2014). Moreover, 
induction of liquid culture of Actinokineospora sp. EG49 
with GlcNAc has resulted in the isolation of and charac-
terization of actinosporins E–H (Dashti et  al. 2017). In 
the current approach, elicitation of the solid culture of 
Actinokineospora spheciospongiae sp. nov. via GlcNAc 
resulted in isolation and characterization of two new 
fridamycins H (1) and I (2), along with three known acti-
nosporins C (3), D (4) and G (5).
On the other side, trypanosomiasis, commonly 
known as sleeping sickness, still has been consid-
ered one of the most serious challenges to human 
health, particularly in underdeveloped regions of 
Africa (Jacobs et  al. 2011; Malvy and Chappuis 2011). 
It is commonly combined with degradation of hepatic 
cells, anemia and glomerulonephritis which are likely 
ascribed to considerable free radicals produced by the 
parasites which attack cellular membrane, leading to 
Fig. 4 Key COSY and HMBC correlations of fridamycin H (1) and I (2)
Page 8 of 9Tawfike et al. AMB Expr            (2019) 9:12 
cellular damages of human vital organs. So far, effec-
tive antitrypanosomally drugs are still not accessible, 
regardless the extensive efforts to achieve treatments 
(Ibrahim et  al. 2013; Steverding 2010). Thus, ongo-
ing research for new classes of metabolites with anti-
trypanosomal activity is necessary. Consequently, 
two new fridamycins H (1) and I (2), along with three 
known actinosporins C (3), D (4) and G (5) were con-
sidered for the examination of the antitrypanosomal 
property versus Trypanosoma brucei TC221 in addi-
tion to cytototoxic properties towards Macrophages 
(J774.1). The results obtained displayed that fridamycin 
H showed significant antitrypanosomal activity after 48 
and 72 h with  IC50 values of 3.38 and 5.26 μM, respec-
tively, with no cytotoxicity against J774.1 macrophages 
 (IC50 > 200  μM). These results demonstrate the poten-
tial of elicitation via compound induction as a tool for 
discovery of new antitrypanosomal chemical scaffolds.
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